Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC).

Valgimigli, Marco; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Landi, Antonio; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Navarese, Eliano Pio; Niebauer, Josef; Oliva, Angelo; Piccolo, Raffaele; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(5), pp. 462-496. Oxford University Press 10.1093/ehjcvp/pvad032

[img]
Preview
Text
pvad032.pdf - Accepted Version
Available under License Publisher holds Copyright.
Author holds Copyright

Download (3MB) | Preview

Multiple guidelines and consensus papers have addressed the role of antithrombotic strategies in patients with established coronary artery disease (CAD). Since evidence and terminology continue to evolve, the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute Cardiovascular Care (ACVC) and European Association of Preventive Cardiology (EAPC) undertook a consensus initiative to guide clinicians to select the optimal antithrombotic regimen for each patient. The aim of this document is to provide an update for clinicians on best antithrombotic strategies in patients with established CAD, classifying each treatment option in relation to the number of antithrombotic drugs irrespective of whether the traditional mechanism of action is expected to mainly inhibit platelets or coagulation cascade. With the aim to reach comprehensiveness of available evidence, we systematically reviewed and performed meta-analyses by means of both direct and indirect comparisons to inform the present consensus document.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2055-6845

Publisher:

Oxford University Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

01 May 2023 15:09

Last Modified:

01 May 2024 00:25

Publisher DOI:

10.1093/ehjcvp/pvad032

PubMed ID:

37120728

Uncontrolled Keywords:

acute coronary syndrome antithrombotic treatment chronic coronary syndrome coronary artery disease percutaneous coronary intervention

BORIS DOI:

10.48350/182153

URI:

https://boris.unibe.ch/id/eprint/182153

Actions (login required)

Edit item Edit item
Provide Feedback